SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000936392-07-000283
Filing Date
2007-04-13
Accepted
2007-04-13 14:37:05
Documents
3
Period of Report
2007-05-24
Effectiveness Date
2007-04-13

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT a29088def14a.htm DEF 14A 776521
2 GRAPHIC a29088a2908800.gif GRAPHIC 2745
3 GRAPHIC a29088a2908801.gif GRAPHIC 912
  Complete submission text file 0000936392-07-000283.txt   783301
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24274 | Film No.: 07765557
SIC: 2836 Biological Products, (No Diagnostic Substances)